Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2369
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis ; volume:16 ; number:1 ; day:19 ; month:4 ; year:2015 ; pages:1-9 ; date:12.2015
BMC nephrology ; 16, Heft 1 (19.4.2015), 1-9, 12.2015
- Creator
-
Kanji, Tahir
- Contributor
-
Gandhi, Mandark
Clase, Catherine M.
Yang, Robert
SpringerLink (Online service)
- DOI
-
10.1186/s12882-015-0047-z
- URN
-
urn:nbn:de:1111-201611057905
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kanji, Tahir
- Gandhi, Mandark
- Clase, Catherine M.
- Yang, Robert
- SpringerLink (Online service)
Other Objects (12)
Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation
Variation in serum urate levels in the absence of gout and urate lowering therapy
Adherence with urate-lowering therapies for the treatment of gout
Factors associated with initiation and persistence of urate-lowering therapy
Impact of urate-lowering drugs on the progression and recovery from chronic kidney disease among gout patients
Effects of Conventional Uric Acid–Lowering Therapy on Monosodium Urate Crystal Deposits
Spectrum and dosing of urate-lowering drugs in a large cohort of chronic kidney disease patients and their effect on serum urate levels: a cross-sectional analysis from the German Chronic Kidney Disease study
Association between urate-lowering therapies and cognitive decline in community-dwelling older adults
Baseline urate level and renal function predict outcomes of urate-lowering therapy using low doses of febuxostat and benzbromarone: a prospective, randomized controlled study in a Chinese primary gout cohort
Risk of chronic kidney disease in patients with gout and the impact of urate lowering therapy: a population-based cohort study
Urate-Lowering Agents in Asymptomatic Hyperuricemia: Role of Urine Sediment Analysis and Musculoskeletal Ultrasound
SLC2A9 (GLUT9) mediates urate reabsorption in the mouse kidney
Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation
Variation in serum urate levels in the absence of gout and urate lowering therapy
Adherence with urate-lowering therapies for the treatment of gout
Factors associated with initiation and persistence of urate-lowering therapy
Impact of urate-lowering drugs on the progression and recovery from chronic kidney disease among gout patients
Effects of Conventional Uric Acid–Lowering Therapy on Monosodium Urate Crystal Deposits
Spectrum and dosing of urate-lowering drugs in a large cohort of chronic kidney disease patients and their effect on serum urate levels: a cross-sectional analysis from the German Chronic Kidney Disease study
Association between urate-lowering therapies and cognitive decline in community-dwelling older adults
Baseline urate level and renal function predict outcomes of urate-lowering therapy using low doses of febuxostat and benzbromarone: a prospective, randomized controlled study in a Chinese primary gout cohort
Risk of chronic kidney disease in patients with gout and the impact of urate lowering therapy: a population-based cohort study
Urate-Lowering Agents in Asymptomatic Hyperuricemia: Role of Urine Sediment Analysis and Musculoskeletal Ultrasound
SLC2A9 (GLUT9) mediates urate reabsorption in the mouse kidney
Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation
Variation in serum urate levels in the absence of gout and urate lowering therapy
Adherence with urate-lowering therapies for the treatment of gout
Factors associated with initiation and persistence of urate-lowering therapy
Impact of urate-lowering drugs on the progression and recovery from chronic kidney disease among gout patients
Effects of Conventional Uric Acid–Lowering Therapy on Monosodium Urate Crystal Deposits
Spectrum and dosing of urate-lowering drugs in a large cohort of chronic kidney disease patients and their effect on serum urate levels: a cross-sectional analysis from the German Chronic Kidney Disease study
Association between urate-lowering therapies and cognitive decline in community-dwelling older adults
Baseline urate level and renal function predict outcomes of urate-lowering therapy using low doses of febuxostat and benzbromarone: a prospective, randomized controlled study in a Chinese primary gout cohort
Risk of chronic kidney disease in patients with gout and the impact of urate lowering therapy: a population-based cohort study
Urate-Lowering Agents in Asymptomatic Hyperuricemia: Role of Urine Sediment Analysis and Musculoskeletal Ultrasound